Skip to main content

Table 1 Baseline characteristics

From: Characterization of the circulating transcriptome expression profile and identification of novel miRNA biomarkers in hypertrophic cardiomyopathy

All (N = 22)

HCM (N = 16)

HOCM (N = 8)

HNCM (N = 8)

Parameters

HCM N = 16

NC N = 6

P

HOCM N = 8

HNCM N = 8

P

Gene ( +) N = 4

Gene (−) N = 4

P

Gene ( +) N = 4

Gene (−) N = 4

P

Age, years

43.19 (10.18)

35.67 (12.99)

0.167

43.50 (8.72)

42.88 (12.08)

0.907

42.50 (7.33)

44.50 (11.00)

0.772

38.25 (10.40)

47.50 (13.23)

0.314

Sex (N, %)

13 (81.25)

4 (66.67)

0.585

6 (75.00)

7 (87.50)

 > 0.999

3 (0.75)

4 (1.00)

 > 0.999

2 (0.50)

4 (1.00)

0.429

BMI, kg/m2

25.89 (2.71)

22.80 (2.06)

0.020

25.19 (2.53)

26.59 (2.86)

0.318

24.02 (2.74)

26.36 (1.95)

0.213

24.61 (1.65)

28.57 (2.43)

0.035

SBP, mmHg

123.69 (15.91)

127.17 (10.21)

0.625

116.38 (17.14)

131 (11.25)

0.063

107.75 (16.92)

125.00 (14.17)

0.169

128.25 (16.26)

133.75 (3.30)

0.532

DBP, mmHg

73.88 (13.10)

78.50 (6.75)

0.424

68 (16.33)

79.75 (4.74)

0.071

63.25 (5.85)

72.75 (22.97)

0.453

78.25 (5.56)

81.25 (3.95)

0.413

MWT, mm

24.69 (5.69)

8.17 (0.98)

 < 0.001

26.00 (5.81)

23.38 (5.63)

0.374

25.50 (7.77)

26.50 (4.20)

0.828

24.75 (5.50)

22.00 (6.22)

0.532

LVOTGrest, mmHg

21.00 (4.75, 72.00)

3.00 (2.75, 3.25)

0.001

24.00 (22.00, 30.75)

5.50 (4.00, 12.00)

0.001

33.50 (28.75, 66.00)

86.50 (72.00, 102.50)

0.081

5.50 (4.00, 12.25)

6.50 (3.25, 12.00)

0.767

LVOTGmax, mmHg

49.50 (13.48, 120.75)

–

 

119.50 (96.75, 126.78)

13.95 (8.15, 19.25)

0.001

108.00 (78.00, 120.75)

125.85 (103.00, 135.43)

0.149

13.95 (9.25, 18.73)

12.80 (8.15, 25.25)

0.885

LAD, mm

41.88 (6.33)

33.33 (1.03)

 < 0.001

43.75 (7.11)

40.00 (5.24)

0.249

48.00 (5.35)

39.50 (6.40)

0.088

39.00 (4.97)

41.00 (6.06)

0.628

RAD, mm

32.31 (4.44)

30.83 (0.98)

0.226

32.50 (4.78)

32.13 (4.39)

0.873

33.75 (4.35)

31.25 (5.50)

0.503

31.25 (5.19)

33.00 (4.00)

0.612

EDV, ml

78.81 (15.01)

71.50 (2.95)

0.080

78.13 (10.59)

79.50 (19.22)

0.862

77.75 (12.42)

78.50 (10.34)

0.929

75.00 (26.99)

84.00 (8.91)

0.550

ESV, ml

31.31 (9.66)

29.33 (1.86)

0.445

31.00 (6.91)

31.63 (12.33)

0.902

30.00 (5.23)

32.00 (9.02)

0.714

29.50 (15.84)

33.75 (9.58)

0.662

E/A

0.85 (0.29)

1.19 (0.20)

0.019

0.81 (0.27)

0.89 (0.33)

0.623

0.93 (0.30)

0.70 (0.20)

0.256

0.73 (0.14)

1.05 (0.41)

0.220

E/e’

12.75 (10.55, 15.50)

6.90 (6.30, 7.29)

0.002

15.71 (6.87)

11.88 (2.28)

0.157

14.08 (3.48)

17.34 (9.54)

0.544

11.45 (3.10)

12.30 (1.44)

0.637

LVEF (%)

60.81 (5.37)

58.67 (1.97)

0.185

60.63 (4.75)

61.00 (6.26)

0.895

61.50 (2.89)

59.75 (6.50)

0.640

62.00 (6.33)

60.00 (6.98)

0.686

  1. Data are expressed as mean (SD), otherwise specified
  2. HOCM obstructive hypertrophic cardiomyopathy, HNCM non-obstructive hypertrophic cardiomyopathy, BMI body mass index; SBP systolic blood pressure, DBP diastolic blood pressure, MWT maximum wall thickness, LVOTGrest the maximum left ventricular outflow tract gradient (at rest), LVOTGmax the maximum LVOTG at provocation, LAD transverse diameter of left atrium, RAD transverse diameter of right atrium, EDV end-diastolic volume, ESV end-systolic volume, E peak flow velocity of early diastolic wave (mitral valve), A peak flow velocity of late diastolic wave (mitral valve), E’ peak flow velocity of early diastolic wave (mitral annular), LVEF left ventricular ejection fraction